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RESEARCH

Chronic Wasting Disease Prions
in Elk Antler Velvet
Rachel C. Angers,1 Tanya S. Seward, Dana Napier, Michael Green, Edward Hoover, Terry Spraker,
Katherine O’Rourke, Aru Balachandran, and Glenn C. Telling

Chronic wasting disease (CWD) is a contagious, fatal
prion disease of deer and elk that continues to emerge in
new locations. To explore the means by which prions are
transmitted with high efficiency among cervids, we examined
prion infectivity in the apical skin layer covering the growing
antler (antler velvet) by using CWD-susceptible transgenic
mice and protein misfolding cyclic amplification. Our finding
of prions in antler velvet of CWD-affected elk suggests that
this tissue may play a role in disease transmission among
cervids. Humans who consume antler velvet as a nutritional
supplement are at risk for exposure to prions. The fact that
CWD prion incubation times in transgenic mice expressing
elk prion protein are consistently more rapid raises the possibility that residue 226, the sole primary structural difference between deer and elk prion protein, may be a major
determinant of CWD pathogenesis.

C

hronic wasting disease (CWD) of deer, elk, and
moose is the only recognized prion disease of wild
animals. To date, 15 US states and 2 Canada provinces
have reported CWD in wild and/or farm-raised cervids.
Outbreaks have also occurred in South Korea as a result
of importation of subclinically infected animals (1,2). The
unparalleled efficiency of prion transmission in cervids by
a largely undefined mechanism, combined with high deer
densities in certain areas of North America, complicates
strategies for controlling CWD as it continues to emerge
in new locations.
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Growing antlers of male cervids are covered by a highly innervated and vascularized apical skin layer, referred
to as velvet, which is shed after an increase in testosterone and ossification of antlers. Our study objective was
to assess whether velvet from CWD-infected elk contains
prion infectivity. Our rationale was 2-fold. First, the annual shedding of this material raises the possibility that it
may play a role in CWD transmission. Second, although
the most likely means of human exposure to CWD prions
is consumption of contaminated venison (3), the substantial
market for velvet in traditional Asian medicine also warrants concern.
We used CWD-susceptible transgenic (Tg) mice as a
sensitive means to detect prions in antler velvet. Bioassays
in Tg mice expressing deer prion protein (PrP) (4) and newly created Tg mice expressing elk PrP, demonstrated low
levels of CWD prions in antler velvet. We also show that
the associated protease-resistant PrP could be amplified in
vitro (for detection by Western blot) by protein misfolding
cyclic amplification (PMCA). Finally, comparative CWD
transmissions in Tg mice indicated that the glutamine (Q)
to glutamic acid (E) variation at residue 226, which is the
sole primary structural difference between deer and elk
PrP, may be a major determinant of CWD pathogenesis in
these 2 species.
Materials and Methods
Production of Transgenic Mice

Tg(CerPrP)1536+/– mice expressing deer PrP have
been described previously (4). To generate Tg(CerPrPE226) mice expressing the elk PrP coding sequence, codon
226 of the deer PrP gene (PRNP) (GenBank accession no.
Current affiliation: Medical Research Council Laboratory of
Molecular Biology, Cambridge, UK.
1
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AF009180) was mutated from Q to E by site-directed mutagenesis (Quick Change; Stratagene, La Jolla, CA, USA).
The resulting expression cassette, CerPrP-E226, highlights
the single amino acid difference between deer and elk PrP
at this position (5). The coding sequence was inserted into
the MoPrP.Xho expression vector, and the purified transgene was microinjected into pronuclei of fertilized FVB/
Prnp0/0 oocytes. Transgenic founders were identified by
PCR screening of genomic DNA. Three Tg(CerPrP-E226)
founders (Tg5029, Tg5034, Tg5037) were mated to FVB/
Prnp0/0 mice to produce hemizygous transgenic lines. Because of equivalent levels of CerPrP-E226 expression,
studies were not duplicated in the Tg5034+/– and Tg5037+/–
lines. Estimates of the levels of PrP expression in 3 different Tg5037+/– mice and 5 different Tg5029+/– mice were
accomplished by immuno-dot blotting and Western blotting using monoclonal antibody (MAb) 6H4 (Prionics,
Schlieren, Switzerland).
Preparation of Prion Inocula

Antler velvet and matching brain samples were obtained from 4 elk from Canada that were naturally affected
with CWD. Elk 01-0306 had severe CWD-specific neuropathologic changes in the obex and neurologic signs indicative of CWD; elk 02-0306 had moderate neuropathologic
changes in the obex and was clinically normal. Although
information about the clinical status of elk 03-0306 and
04-0306 was not available, these elk had mild and severe
neuropathologic changes, respectively, in the obex. Brain
samples were also obtained from CWD-affected mule deer
D10 and D92 at the Colorado Division of Wildlife, Wildlife Research Center, and from CWD-affected elk 7378 and
99W12389 at the Wyoming Game and Fish Department’s
Sybille Wildlife Research Unit. Homogenates of brain and
antler velvet (10% wt/vol) were prepared in sterile phosphate-buffered saline (PBS) lacking Ca2+ and Mg2+ ions.
Measurement of Incubation Times

Groups of 5-week-old Tg mice were given general anesthesia and inoculated with 30 µL of brain or antler velvet
homogenate through a 27-gauge needle inserted into the
right parietal lobe of the brain. Mice were observed 3 times
a week for clinical signs indicative of prion infection, e.g.,
ataxia, weight loss, hyperactivity, flattened posture, absent
extensor reflex, or kyphosis. The incubation period is the
time between inoculation and the first day on which subsequently progressive clinical signs were identified. For endpoint titration, groups of 8 Tg mice were inoculated with
10–1 to 10–10 dilutions of a 10% brain homogenate of D92
prepared in PBS lacking Ca2+ and Mg2+ ions.
Western Blotting

Protein content in 10% brain homogenates was deter-

mined by bicinchoninic acid assay. Total protein (50 μg)
was then digested with 40 μg/mL proteinase K (PK) (Roche,
Mannheim, Germany) in the presence of 2% sarkosyl for 1
h at 37°C. Digestion was terminated with phenylmethylsulfonyl fluoride at a final concentration of 5 μM. Proteins
were resolved by sodium dodecyl sulfate–polyacrylamide
gel electrophoresis and transferred to polyvinylidene difluoride Immobilon-FL membranes (Millipore, Billerica,
MA, USA), which were immunoprobed with MAb 6H4
followed by horseradish peroxidase–conjugated antimouse
secondary antibody. Proteins were visualized by using
ECL Plus (GE Healthcare, Piscataway, NJ, USA) and an
FLA-5000 scanner (Fujifilm Life Science, Woodbridge,
CT, USA).
Histoblotting

Coronal cryostat sections (10 μm) were transferred to
nitrocellulose and probed with MAb 6H4 after PK digestion as described previously (6). Images were photographed
with a NikonDMX 1200F (Tokyo, Japan) digital camera in
conjunction with Metamorph software (Molecular Devices,
Sunnyvale, CA, USA).
Immunohistochemical Analysis

Sections (8 μm) of formalin-fixed, paraffin-embedded
mouse brains on positively charged microscope slides were
deparaffinized and subjected to immunohistochemical
analysis to deter the disease-associated form of PrP (PrPSc)
as described previously (7). PrPSc was detected with MAb
6H4 after hydrolytic autoclaving for 15 min in 10 mmol/L
HCl. Biotinylated secondary antibody in conjunction with
3,3′-diaminobenzidine was used to visualize PrPSc.
PMCA

Healthy Tg(CerPrP)1536+/– mice were perfused with
PBS/5 mM EDTA. Brain homogenates (10% wt/vol) were
prepared in conversion buffer consisting of PBS containing 150 mmol/L NaCl, 1.0% Triton X-100, and Roche’s
Complete Protease Inhibitor Cocktail. Samples were clarified by centrifugation at 500 rpm for 60 s. Each PMCA
cycle consisted of 30 min incubation at 37°C followed by
a 20 s sonication pulse at setting 7 using a Misonix 3000
Sonicator (Misonix, Farmingdale, NY, USA). After 96 cycles, 6 μL of the 60-μL reaction was diluted into 54 μL of
fresh Tg(CerPrP)1536+/– substrate for a subsequent round
of PMCA. Amplification products were digested with 50
μg/mL PK at 50°C for 75 min.
Results
CWD Prions in Elk Antler Velvet

Mean incubation periods for mice inoculated with
CWD prions from elk brains were more uniform (225–
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335 days) than were those for mice inoculated with CWD
prions from antler velvet. Not all Tg(CerPrP)1536+/– mice
inoculated with antler velvet developed disease; incubation times for those that did were relatively long and
highly variable (Table). Clinical signs did develop in
Tg(CerPrP)1536+/– mice challenged with antler velvet
from elk 01-0306 and 03-0306; mean incubation periods
were ≈440 d and ≈460 d and attack rates were 75% and
66%, respectively. Tg(CerPrP)1536+/– mice inoculated
with antler velvet from elk 02-0306 and 04-0306 remained healthy until the mice were euthanized at ≈600 d
postinoculation.
We also tested the susceptibility of Tg mice expressing elk PrP. Mean incubation times after inoculation of Tg(CerPrP-E226)5037+/– mice with CWD prions
from brains of elk 01-0306 and 04-0306 were 174 ± 7 d
and 224 ± 6 d, respectively (Table). Of the Tg(CerPrPE226)5037+/– mice inoculated with antler velvet from elk
01-0306, 29% died of prion disease in <400 d, and antler
velvet from elk 04-0306 failed to induce disease (Table);
this finding confirmed the antler velvet transmission results
in Tg(CerPrP)1536+/– mice.
Tg(CerPrP-E226)5037+/– mice express PrP at ≈5-fold
the level of PrP in the brains of wild type mice, similar to
transgene expression levels in Tg(CerPrP)1536+/– mice; the
level of expression in Tg(CerPrP-E226)5029+/– mice was
approximately equal to that in wild type mice (Figure 1).
Induction of disease by CWD prions in brain from diseased
elk and deer was consistently and significantly more rapid
in Tg(CerPrP-E226)5037+/– than in Tg(CerPrP)1536+/–
mice (Table). Mean incubation times of the D92 isolate
were equivalent in Tg(CerPrP)1536+/– and Tg(CerPrPE226)5029+/– mice (Table), which have a 5-fold difference
in transgene expression levels (Figure 1).

PrPSc Accumulation and Neuropathologic
Changes in Diseased Tg Mice

Diagnoses for all Tg(CerPrP)1536+/– and Tg(CerPrPE226)5037+/– mice were confirmed by the presence or absence of protease-resistant PrPSc in brains, according to
Western blotting (Figure 2) and histoblotting (Figure 3)
and finding of disease-specific neuropathologic changes
(Figure 4). PrPSc immunostaining in histoblots of diseased
Tg(CerPrP)1536+/– and Tg(CerPrP-E226)5037+/– mice
was punctate (Figure 3). Although cortical florid plaques
were observed in the brains of diseased Tg(CerPrP)1536+/–
mice (Figure 4, panels A and B), PrPSc accumulation in
Tg(CerPrP-E226)5037+/– mice was more diffuse and granular. The extensive loss of cerebellar granular cells and accompanying PrPSc deposition that characterized disease in
Tg(CerPrP-E226)5037+/– mice (Figure 4, panels G and H)
was not noted for Tg(CerPrP)1536+/– mice (Figure 4, panels
C and D).
Estimates of CWD Prion Titers in Antler Velvet

A brainstem preparation from CWD-affected mule
deer D92, which contained high levels of PrPSc according
to Western blot (data not shown), was selected for endpoint titration of CWD prions in Tg(CerPrP)1536+/– mice.
Disease developed in all mice inoculated with the 3 lowest
dilutions; mean incubation periods ranged from 268 to 390
d (Figure 5). Disease did not develop in any of the mice
inoculated with the 10–4 dilution, but disease did develop
after 471 d in 1 mouse from the 10–5 dilution group. The
remaining mice in the 10–5 dilution group and all mice inoculated with higher dilutions remained free of disease and
were euthanized after 560–645 d. The disease status of all
mice was confirmed by Western blotting (data not shown).
We estimated the titer of CWD prions in D92 brain tissue

Table. Transmission of chronic wasting disease prions to transgenic mice*
C
C
Mice expressing deer PrP
Mice expressing elk PrP
+/–
+/–
+/–
Tg(CerPrP)1536
Tg(CerPrP-E226)5037
Tg(CerPrP-E226)5029
Isolate from
animal no.
Antler velvet
Brain
Antler velvet
Brain
Brain
% Decrease†
01-0306
442 ± 16 (6/8)
322 ± 9 (8/8)
305 ± 86 (2/7)‡
174 ± 7 (8/8)
46 (<0.0001)
02-0306
>594 (0/5)
225 ± 3 (7/7)
03-0306
463 ± 23 (2/3)§
335 ± 5 (7/7)
04-0306
>601 (0/6)
281 ± 5 (7/7)
>505 (0/5)
224 ± 6 (7/7)
20 (<0.0001)
7378
235 ± 2 (8/8)
177 ± 15 (7/7)
25 (0.0061)
99W12389
230 ± 9 (8/8)
158 ± 13 (7/7)
31 (0.0004)
D10
225 ± 1 (8/8)
201 ± 8 (8/8)
11 (0.013)
D92
268 ± 15 (7/7)
201 ± 15 (8/8)
263 ± 10 (7/7)
25 (0.0061)
PBS
>510 (0/6)
None
>592 (0/4)¶

*Incubation times are given as mean ± SEM days. Values in parentheses are no. diseased mice/no. inoculated mice. PrPC, cellular prion protein; Tg,
transgenic; PBS, phosphate-buffered saline.
†Values represent the percent decrease in mean incubation time of isolates in Tg(CerPrP-E226)5037+/– mice compared with Tg(CerPrP)1536+/– mice.
p values, calculated by the Student t-test, are shown in parentheses.
‡The remaining 5 of 7 inoculated mice remained free of disease until 525 d postinoculation, at which time they were euthanized.
§Mice inoculated with the antler velvet preparation from elk 03-0306 had an unusually high rate of intercurrent illnesses, resulting in early euthanasia of 5
inoculated mice.
¶Four uninoculated Tg(CerPrP E2226) 5037+/– mice were euthanized at 437 d.
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Figure 1. Levels of transgene expression in transgenic (Tg) mice
expressing deer or elk cellular prion protein (PrPC). Representative
Western blot analysis of PrPC expression from different total protein
loads in brain extracts from Tg mice Tg(CerPrP)1536+/–, Tg(CerPrPE226)5029+/–, and Tg(CerPrP-E226)5037+/– compared with wild
type and Prnp0/0 mice (knock-out mice for PrP gene).

to be 6 log i.c. ID50/g (i.c. ID50 refers to the dose of CWD
prions that produces infection in 50% of the intracerebrally
inoculated Tg mice) (8).
The inefficient transmission of prions from antler velvet samples (Table) is consistent with low levels of CWD
prions. Because the incubation times of CWD prions in
antler velvet from elk 01-0306 and 03-0306 were outside
the linear range of dose and incubation time (Figure 5), we
were unable to assign a definitive titer. The infection attack
rates <100% suggested that CWD prion titers in these 1%
inocula were close to, or at, the end point of the bioassay
(<3.5 log i.c.ID50 units).
Amplification of PrPSc in Antler Velvet Preparations

When Western blot, ELISA, and immunohistochemical analyses failed to detect PrPSc in antler velvet samples

from 14 CWD-affected elk, including the 4 samples analyzed by bioassay (data not shown), we attempted to amplify PrPSc in antler velvet samples by using serial PMCA
(Figure 6). Whereas PrPSc in brain homogenates of elk
01-0306, 03-0306, and 04-0306 was efficiently amplified,
even at high dilution, after 1 or 2 rounds of PMCA, PrPSc
in antler velvet homogenates of elk 01-0306 and 03-0306
was not amplified until either round 3 or 4. PrPSc was not
amplified in antler velvet from elk 04-0306 or after PMCA
of negative-control preparations. PrPSc amplification correlated with the transmission efficiency of CWD prions in
antler velvet. The antler velvet sample from elk 01-0306,
which produced detectable amplification products after
3 rounds of PMCA, caused disease in Tg(CerPrP)1536+/–
mice (mean incubation time 442 d, attack rate 75%) and in
Tg(CerPrP-E226)5037+/– mice. The velvet sample from elk
03-0306, which produced detectable amplification products
after 4 rounds of PMCA, and resulted in a 463-d mean incubation time and a 66% attack rate. In contrast, the antler
velvet sample from elk 04-0306, which failed to amplify
after 4 rounds of PMCA, also failed to transmit prions to
either Tg mouse line.
Discussion
The transmission of CWD prions in antler velvet from
2 naturally affected elk to mice in 2 Tg models demonstrates that this tissue contains low, but detectable, amounts
of CWD prions. In addition, serial PMCA amplified otherwise undetectable levels of PrPSc in antler velvet.
We characterized CWD prion infectivity by end-point
titration. The ≈6 log i.c.ID50/g CWD prion titer estimated
by this method contrasts with ≈9 log i.c.ID50/g titers of
mouse-adapted scrapie prions in rodent brains (9) and
≈7–7.7 log i.c.ID50/g titers of BSE prions estimated by
bioassay in transgenic mice (10,11). The linear relationship between dose and incubation time (12) provides an
opportunity to estimate the level of prions in materials containing an unknown amount of infectivity. The attack rates
of <100% after inoculation with antler velvet preparations
from elk 01-0306 and 03-0306 and the failure to transmit
disease from the remaining antler velvet samples suggest

Tg(CerPrP)1536+/−
Inoculum

PK

PBS

01-0306
B
A

−

03-0306
B
A

Tg(CerPrP-E226)5037+/−

PBS 01-0306
B
A

+

03-0306
B
A

None 01-0306
B A

−

+

Figure 2. Accumulation of PrPSc
(disease-associated form of prion
protein) in diseased transgenic
(Tg) mice. Tg(CerPrP)1536+/– and
Tg(CerPrPE226)5037+/– mice inoculated with phosphate-buffered
saline (PBS), elk brain (B), or
antler velvet (A) were treated
with or without proteinase K
(PK). Membranes were probed
with monoclonal antibody 6H4.
Molecular weights indicated are
37, 29, and 20 kD.
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Antler Velvet

Brain

Antler Velvet

Hippocampus

Midbrain

Oblongata

Tg(CerPrP)1536+/−

Tg(CerPrP-E226)5037+/−

Figure 3. Distribution of PrPSc (disease-associated form of prion protein) in brains of diseased mice. Histoblots of mice inoculated with 010306 brain or antler velvet material were treated with proteinase K and probed with monoclonal antibody 6H4. Tg, transgenic.

that CWD prion titers are close to, or at, the end point of
the Tg(CerPrP)1536+/– bioassay. Although we are aware
of the limitations of comparing levels of prions in tissues
from different CWD-affected cervids, we estimated the end
point of the CWD prion titration using D92 to be <3.5 log
Recipient
Inoculum

i.c.ID50 units. Other factors could also influence levels of
infectivity in the 4 tested samples, e.g., the portion of the
antler processed and the age of the antler when harvested.
Histologic evaluation indicated that the velvet samples used
in these transmission studies came from elk antlers in the

Tg(CerPrP)1536+/−
01-0306 Brain

Tg(CerPrP-E226)5037+/−

01-0306 Antler

01-0306 Brain

01-0306 Antler

A

B

E

F

C

D

G

H

Figure 4. PrPSc (disease-associated form of prion protein)–specific immunohistochemistry in the brains of diseased mice. Transgenic (Tg)
mice Tg(CerPrP)1536+/– inoculated with brain (A) and antler velvet (B) preparations from elk 01-0306 exhibit florid PrPSc-reactive plaques
in the cerebral cortex at the level of the thalamus but retain integrity of cerebellar granular cells (C and D). Tg(CerPrP-E226)5037+/– mice
inoculated with brain (E) and antler velvet (F) preparations from elk 01-0306 display small plaques and diffuse granular staining in the
cerebral cortex, PrPSc deposition, and marked cerebellar neuronal loss (G and H).
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Dilution
Incubation, d
No. mice (n/n0)

10–1

10–2

10–3

10–4

268 ± 15 323 ± 14 390 ± 3

7/7

8/8

6/6

10–5

10–6

10–7

10–8

10–9

10–10

0/8

0/8

0/7

0/6

0/3

485

0/6

1/8

Figure 5. Quantification of chronic wasting disease prions. Diseased
transgenic (Tg) mice Tg(CerPrP)1536+/– inoculated with dilutions of
brain homogenate are indicated by filled symbols Asymptomatic
mice are indicated by open circles; time at which asymptomatic
aged mice were either euthanized or died of illnesses unrelated to
prion disease is shown. Error bars indicate SEM. n/n0 refers to the
number of mice developing prion disease divided by the number
of inoculated mice. Also shown are the mean incubation times of
diseased Tg(CerPrP)1536+/– mice inoculated with antler velvet
preparations (filled squares).

early stages of seasonal growth (data not shown). Whether
CWD prion titers in antler velvet vary according to the state
of antler growth remains to be determined. Whether prion
infectivity is derived from nervous system tissue, blood
(13), or another component of velvet, is also unclear.
Implications for Horizontal CWD Transmission and Human Exposure

Our studies indicate that antler velvet represents a previously unrecognized source of CWD prions in the environment. Whereas oral transmission of rodent-adapted scrapie
prions is known to be ≈5 orders of magnitude less efficient
than transmission by intracerebral inoculation (14,15), the
relative efficiency of oral CWD prion transmission is unknown. Multiple exposures to low levels of CWD prions
in the environment (16,17), as well as increased infectivity
when prions are bound to soil minerals (18), are factors that
may influence transmission.
The appearance of variant Creutzfeldt-Jakob disease
in humans exposed to bovine spongiform encephalopathy
(BSE) (19,20) and the demonstration of CWD prions in
muscle (3) placed the human species barrier to CWD prions
at the forefront of public health concerns. Our studies indicate that antler velvet represents an additional source for
human exposure to CWD prions. Widely used in traditional
Asian medicine to treat a variety of ailments including impotence, arthritis, and high blood pressure, antler velvet

can be readily purchased in caplet form and its usage has
increased worldwide.
Fortunately, to date there is no epidemiologic evidence
that rates of CJD in the CWD-endemic region (Colorado,
USA) have increased (21,22). Also reassuring is the inefficient in vitro conversion of human PrP to protease-resistant
PrP by CWD (23). Two studies have shown that CWD prions failed to induce disease in Tg mice expressing human
PrP (24,25). However, the failure of BSE to be transmitted to Tg mice expressing human prion protein (HuPrP)
was cited as early evidence of a BSE transmission barrier
in humans (26); subsequent studies demonstrated a strong
effect of the codon 129 polymorphism on transmissibility
of BSE prions (27). To date, only mice expressing HuPrP
with methionine at 129 have been challenged with CWD.
In support of the argument that humans might be susceptible to CWD, intracerebral inoculation of squirrel monkeys
produced disease after >30 months (28). Prion strain properties are also critical when considering the potential for
interspecies transmission. The existence of multiple CWD
strains has been suggested by several studies (4,25,29,30),
but strain isolation and host range characterization have not
been reported. Finally, it is worth considering that if CWD
were to cross the species barrier into humans, this transmission source might not be recognized if the disease profile
overlapped with one of the forms of sporadic CJD reported
in North America.
Possible Role for Residue 226 in CWD Pathogenesis

Previous studies that demonstrated more rapid CWD
prion incubation times in Tg mice expressing elk PrP (24,29)
than in Tg(CerPrP)1536+/– mice (4) raised the possibility that
the single amino acid difference at residue 226 between elk
and deer PrP (5) may influence CWD pathogenesis (29).
However, when the transmission characteristics of CWD
isolates were directly compared in Tg mice expressing differing levels of deer or elk PrP, Tamgüney et al. concluded
that CWD incubation times were related solely to the level
of PrP transgene expression (25). We compared CWD transmission in Tg(CerPrP-E226)5037+/– and Tg(CerPrP)1536+/–
mice, which express PrP at levels ≈5-fold higher than PrP
levels in wild type mouse brain (Figure 1A), and found that
CWD transmission was consistently and substantially more
rapid in Tg(CerPrP-E226)5037+/– mice. Our results appear
compatible with more efficient CWD prion propagation by
elk cellular prion protein (CerPrPC) containing E at residue
226 than by deer CerPrPC containing Q at this position. Consistent with this interpretation, despite 5-fold lower levels of
transgene expression in Tg(CerPrP-E226)5029+/– mice than
in Tg(CerPrP)1536+/– mice, mean incubation times of the
D92 isolate were equivalent in these 2 lines (Table). Nonetheless, undetected differences in CerPrPC expression, for
example in particular cell types, might result in more rapid
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Figure 6. Detection of CerPrPSc (disease-associated form of cervid prion protein [PrP]) in brain and antler velvet from chronic wasting
disease (CWD)–affected elk after serial protein misfolding cyclic amplification (PMCA). Western blots demonstrate amplification of
protease-resistant prion protein (PrP) after serial PMCA when seeded with brain or velvet antler material from CWD-affected elk. Brain
samples: lane 1, Tg(CerPrP)1536+/– brain material not treated with proteinase K (PK); lane 2, Tg(CerPrP)1536+/– brain material used as a
negative control seed for the PMCA reactions; lanes 3–9, 10–2 to 10–8 dilutions of 10% elk brain homogenate. Antler velvet samples: lane
1, Tg(CerPrP)1536+/– brain material not treated with PK; lane 2, Tg(CerPrP)1536+/– brain material used as a negative control seed for the
PMCA reactions; lanes 3–9, replicate 10–2 dilutions of 10% antler velvet homogenate. Samples were either treated or not treated with PK
as indicated. Membranes were probed with monoclonal antibody 6H4. Tg, transgenic.

disease and/or altered pathologic changes. The generation of
transgenic mice expressing elk and deer coding sequences
using gene replacement strategies would seem to be an excellent approach for resolving this issue.
The different responses to CWD in Tg mice also appear
to recapitulate aspects of CWD pathogenesis in the natural hosts. Previous limited comparative transmission studies indicated that CWD developed ≈25% more rapidly in
orally challenged elk than deer (31). Although plaques were
not detected in brains of CWD-affected elk, florid plaques
have been observed in the brains of diseased deer (32,33).
Similar differences in pathologic changes were observed in
Tg(CerPrP-E226)5037+/– and Tg(CerPrP)1536+/– mice (Figure 4). Structural analyses suggest that residue 226 is located
within a region of PrPC proposed to interact with a factor
(34), possibly equivalent to the postulated protein X (35).
Although mutation of the equivalent residue from Q to lysine
(K) in epitope-tagged mouse PrP had no effect on PrPSc formation in transfected chronically infected ScN2A cells, the
effects of the Q-to-E substitution were not assessed (36).
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